We are live on ! Find out more
CAH icon

Cardinal Health

722 hedge funds and large institutions have $17.4B invested in Cardinal Health in 2017 Q4 according to their latest regulatory filings, with 120 funds opening new positions, 221 increasing their positions, 288 reducing their positions, and 103 closing their positions.

New
Increased
Maintained
Reduced
Closed

17% more first-time investments, than exits

New positions opened: 120 | Existing positions closed: 103

1% more funds holding

Funds holding: 712722 (+10)

0.96% more ownership

Funds ownership: 89.22%90.19% (+0.96%)

0% more funds holding in top 10

Funds holding in top 10: 44 (0)

8% less capital invested

Capital invested by funds: $18.8B → $17.4B (-$1.43B)

23% less repeat investments, than reductions

Existing positions increased: 221 | Existing positions reduced: 288

50% less call options, than puts

Call options by funds: $54.8M | Put options by funds: $110M

Holders
722
Holders Change
+10
Holders Change %
+1.4%
% of All Funds
16.38%
Holding in Top 10
4
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.09%
New
120
Increased
221
Reduced
288
Closed
103
Calls
$54.8M
Puts
$110M
Net Calls
-$54.9M
Net Calls Change
-$17.3M
Name Holding Trade Value Shares
Change
Change in
Stake
TSW
26
Thompson Siegel & Walmsley
Virginia
$105M +$16.3M +264,271 +18%
Goldman Sachs
27
Goldman Sachs
New York
$103M -$40.7M -659,060 -28%
TA
28
Teachers Advisors
New York
$101M -$2.39M -38,595 -2%
TG
29
TCW Group
California
$94.2M +$9.8M +158,501 +11%
Morgan Stanley
30
Morgan Stanley
New York
$93.6M -$7.02M -113,478 -7%
JP Morgan Chase
31
JP Morgan Chase
New York
$91.2M -$5.91M -95,541 -6%
TCIM
32
TIAA CREF Investment Management
New York
$88M -$11.1M -179,141 -11%
Charles Schwab
33
Charles Schwab
California
$82.9M +$4.51M +72,892 +6%
New York State Common Retirement Fund
34
New York State Common Retirement Fund
New York
$81.4M +$7.19M +116,283 +10%
Wells Fargo
35
Wells Fargo
California
$80.8M +$18.2M +293,863 +29%
CB
36
Cooke & Bieler
Pennsylvania
$78.5M -$3.96M -64,066 -5%
Lord, Abbett & Co
37
Lord, Abbett & Co
New Jersey
$77M -$1.97M -31,800 -2%
BIP
38
Brandes Investment Partners
California
$76.8M +$34.3M +554,365 +79%
GC
39
Guggenheim Capital
Illinois
$73.2M +$19.6M +316,772 +36%
UBS AM
40
UBS AM
Illinois
$72M +$2.37M +38,308 +3%
Swiss National Bank
41
Swiss National Bank
Switzerland
$71.4M +$136K +2,200 +0.2%
Dimensional Fund Advisors
42
Dimensional Fund Advisors
Texas
$67.1M +$7.11M +115,001 +12%
ProShare Advisors
43
ProShare Advisors
Maryland
$66M +$14.9M +241,525 +29%
H
44
Hexavest
Quebec, Canada
$61.2M +$980K +15,844 +2%
Two Sigma Advisers
45
Two Sigma Advisers
New York
$57.1M +$22.3M +360,520 +63%
Sumitomo Mitsui Trust Group
46
Sumitomo Mitsui Trust Group
Japan
$56.1M +$1.28M +20,638 +2%
AI
47
Ariel Investments
Illinois
$52.8M +$7.8M +126,122 +17%
Allianz Asset Management
48
Allianz Asset Management
Germany
$51.1M -$13.7M -221,537 -21%
AA
49
ALPS Advisors
Colorado
$50.3M +$50.7M +820,218 New
PPA
50
Parametric Portfolio Associates
Washington
$49.2M +$6.64M +107,438 +15%

CAH Hedge Fund Activity: Q4 2017 in Review

722 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in Cardinal Health (CAH) for Q4 2017, worth a combined $17.4B — down 7.6% from $18.8B a quarter earlier.

Buyers outnumbered sellers: 120 funds opened new CAH positions and 103 closed out — a net gain of 17 holders — while 221 added to existing stakes and 288 trimmed.

The largest buyer was American International Group, adding an estimated $484M. The largest seller was Ameriprise, cutting an estimated $288M.

  • 722 institutional investors held Cardinal Health (CAH) as of Q4 2017, up from 712 in Q3 2017.
  • Funds reported $17.4B of Cardinal Health stock for Q4 2017, down 7.6% quarter-over-quarter.
  • 120 funds opened new Cardinal Health positions in Q4 2017 and 103 closed out, a net change of +17 holders.
  • The largest Cardinal Health buyer in Q4 2017 was American International Group, an estimated $484M added.
  • The largest Cardinal Health seller in Q4 2017 was Ameriprise, an estimated $288M sold.

Based on aggregated 13F filings for Q4 2017.